Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Pidilizumab Biosimilar – Anti-PDCD1, CD279 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Pidilizumab Biosimilar - Anti-PDCD1, CD279 mAb - Research Grade |
|---|---|
| Source | CAS 1036730-42-3 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Pidilizumab,CT-011,PDCD1, CD279,anti-PDCD1, CD279 |
| Reference | PX-TA1312 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1, kappa |
| Clonality | Monoclonal Antibody |
Description of Pidilizumab Biosimilar - Anti-PDCD1, CD279 mAb - Research Grade
General information on Anti-PDCD1/CD279[Homo sapiens] (Pidilizumab) Monoclonal Antibody
Pidilizumab is investigated for treatments of Diffuse Intrinsic Pontine Glioma.
Related products
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.